psychedelics investing Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.